Skip to main content

Advertisement

SpringerLink
Log in

Systolic Pressure, Diastolic Pressure, or Pulse Pressure as a Cardiovascular Risk Factor in Renal Disease

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Chronic kidney disease is a leading global health problem with an increasing prevalence. Hypertension is present in most patients with chronic kidney disease, and hypertension-related nephrosclerosis is a top cause of progressive renal damage and end-stage renal disease. Systolic blood pressure (BP) and pulse pressure, together with nocturnal BP, are the most important factors favoring the progression of renal failure. Consequently, strict control of BP and other cardiovascular risk factors is required, including an adequate degree of suppression of the renin-angiotensin system in every patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Snyder JJ, Collins AJ: KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999–2004. Am J Nephrol 2009, 30:44–54.

    Article  PubMed  Google Scholar 

  2. Mancia G, De Backer G, Dominiczak A, et al.: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:1751–1762

    Article  CAS  PubMed  Google Scholar 

  3. Williams B: The changing face of hypertension treatment: treatment strategies from the 2007 ESH/ESC Hypertension Guidelines. J Hypertens 2009, 27(Suppl 3):S19–S26.

    Article  CAS  Google Scholar 

  4. Tonelli M, Wiebe M, Culleton B, et al.: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006, 17:2034–2047.

    Article  PubMed  Google Scholar 

  5. Ruilope LM, Lahera V, Rodicio JL, et al.: Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension 1994, 23:3–9.

    CAS  PubMed  Google Scholar 

  6. Ruilope LM, Campo C, Rodicio JL: Relationship between blood pressure and renal function. J Hypertens Suppl 1994, 12:S55–59.

    CAS  PubMed  Google Scholar 

  7. Hovind P, Rossing P, Tarnow L, et al.: Progression of diabetic nephropathy. Kidney Int 2001, 59:702–709

    Article  CAS  PubMed  Google Scholar 

  8. Fisher CM: The ascendancy of diastolic blood pressure over systolic. Lancet 1985, 11:1349–1350.

    Article  Google Scholar 

  9. White WB: Systolic versus diastolic blood pressure versus pulse pressure. Curr Cardiol Rep 2002, 4:463–467.

    Article  PubMed  Google Scholar 

  10. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988–1991. Hypertension 1995, 25:305–313.

    CAS  PubMed  Google Scholar 

  11. Black HR: The paradigm has shifted, to systolic blood pressure. Hypertension 1999, 34:386–387.

    CAS  PubMed  Google Scholar 

  12. Sever P: Abandoning diastole. BMJ 1999, 318:1773.

    PubMed  Google Scholar 

  13. Amar J, Chamontin B: Cardiovascular risk factors, atherosclerosis and pulse pressure. Adv Cardiol 2007, 44:212–222.

    Article  CAS  PubMed  Google Scholar 

  14. Benetos A, Zureik M, Morcet J, et al.: A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000, 35:673–680.

    Article  CAS  PubMed  Google Scholar 

  15. Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 355:865–872.

    Article  CAS  PubMed  Google Scholar 

  16. Kannel WB: Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J 1999, 138:205–210.

    Article  CAS  PubMed  Google Scholar 

  17. Strandberg TE, Pitkala K: What is the most important component of blood pressure: systolic, diastolic or pulse pressure? Curr Opin Nephrol Hypertens 2003, 12:293–297.

    Article  PubMed  Google Scholar 

  18. Franklin SS: Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens 1999, 17:S29–S36.

    CAS  Google Scholar 

  19. Schillaci G, Pirro M, Mannarino MR, et al.: Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension 2006, 48:616–621.

    Article  CAS  PubMed  Google Scholar 

  20. Asmar R: Benefits of blood pressure reduction in elderly patients. J Hypertens Suppl 2003, 21:S25–S30.

    CAS  PubMed  Google Scholar 

  21. Franklin SS: Systolic blood pressure: It’s time to take control. Am J Hypertens 2004, 17:49S–54S.

    Article  PubMed  Google Scholar 

  22. Laurent S, Cockcroft J, Van Bortel L, et al.; European Network for Non-Invasive Investigation of Large Arteries: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588–2605.

    Article  PubMed  Google Scholar 

  23. Benetos A, Safar M, Rudnichi A, et al.: Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997, 30:1410–1415.

    CAS  PubMed  Google Scholar 

  24. Gasowski J, Fagard RH, Staessen JA, et al.; INDANA Project Collaborators: Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002, 20:145–151.

    Article  CAS  PubMed  Google Scholar 

  25. Darne B, Girerd X, Safar M, et al.: Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989, 13:392–400.

    CAS  PubMed  Google Scholar 

  26. Lewington S, Clarke R, Qizilbash N, et al.; Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.

    Article  PubMed  Google Scholar 

  27. • Lawes CMM, Van der Horn S, Rodgers A: Global burden of blood pressure related disease, 2001. Lancet 2008, 371:1513–1518. This study assesses the extent and global distribution of the burden of BP-related disease. It concludes that low-income and middle-income countries and middle-aged, prehypertensive people cause most of the disease burden.

    Article  PubMed  Google Scholar 

  28. Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.

    Article  PubMed  Google Scholar 

  29. Sever P: Is systolic blood pressure all that matters? Yes. BMJ 2009, 339:b2665.

    Article  PubMed  Google Scholar 

  30. O’Brien E: Is systolic blood pressure all that matters? No. BMJ 2009, 339:b2669.

    Article  PubMed  Google Scholar 

  31. Franklin SS, Jacobs M, Wong ND, et al.: Predominance of isolated systolic hypertension among middle aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES III). Hypertension 2001, 37:869–874.

    CAS  PubMed  Google Scholar 

  32. •• Williams B, Lindholm LH, Sever P: Systolic pressure is all that matters. Lancet 2008, 371:2219–2222. These authors review evidence supporting the hypothesis that SBP contributes more of the huge global disease burden attributable to hypertension than does DBP.

    Article  PubMed  Google Scholar 

  33. •• Mancia G, Laurent S, Agabiti-Rosei E, et al.: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009, 18:308–347. This is an important review of current guideline recommendations according to results of the latest trials.

    Article  CAS  PubMed  Google Scholar 

  34. •• Zanchetti A, Grassi G, Mancia G: When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009, 27:923–934. This paper is a critical discussion of the most debated items included in the most recent international guidelines.

    Article  CAS  PubMed  Google Scholar 

  35. Stamler J: Epidemiology of coronary heart disease. Med Clin North Am 1973, 57:5–46.

    CAS  PubMed  Google Scholar 

  36. Schram MT, Kostense PJ, Van Dijk RA, et al.: Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 2002, 20:1743–1751.

    Article  CAS  PubMed  Google Scholar 

  37. Martins D, Tareen N, Pan D, Norris K: The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hypertens 2002, 15:538–543.

    Article  PubMed  Google Scholar 

  38. Abramson JL, Weintraub WS, Vaccarino V: Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002, 39:197–202.

    Article  CAS  PubMed  Google Scholar 

  39. Knudsen ST, Poulsen PL, Hansen KW, et al.: Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002, 15:244–250.

    Article  PubMed  Google Scholar 

  40. Kato J, Kitamura K, Uemura T, et al.: Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002, 25:887–892.

    Article  CAS  PubMed  Google Scholar 

  41. Antikainen RL, Jousilahti P, Vanhanen H, Tuomilehto J: Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J Hypertens 2000, 18:417–423.

    Article  CAS  PubMed  Google Scholar 

  42. Strandberg TE, Salomaa VV, Vanhanen HT, et al.: Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens 2002, 20:399–404.

    Article  CAS  PubMed  Google Scholar 

  43. Domanski M, Mitchell G, Pfeffer M, et al.; MRFIT Research Group: Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002, 287:2677–2683.

    Article  PubMed  Google Scholar 

  44. Buckalew VM, Berg RL, Wang SR, et al.: Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996, 28:811–821.

    Article  PubMed  Google Scholar 

  45. • Redon J, Plancha E, Swift P, et al.: Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4. J Hypertens 2010, 28:602–607. This interesting study assesses the role of office and ambulatory blood pressure measurements on the development of ESRD in nondiabetic CKD.

    Article  CAS  PubMed  Google Scholar 

  46. Agarwal R, Anderson MJ: Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006, 69:1175–1180.

    Article  CAS  PubMed  Google Scholar 

  47. Zager PG, Nicolie J, Brown RH, et al.: “U” Curve association of blood pressure and mortality in haemodialysis patients. Kidney Int 1998, 54:561–569.

    Article  CAS  PubMed  Google Scholar 

  48. Agarwal R: Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:830–837.

    Article  PubMed  Google Scholar 

  49. Haider AW, Larson MG, Franklin SS, Levy D: Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003, 138:10–16.

    PubMed  Google Scholar 

  50. Tozawa M, Iseki K, Oshiro S, et al.: Evidence for elevated pulse pressure in patients on chronic haemodialysis: A case-control study. Kidney Int 2002, 62:2195–2201.

    Article  PubMed  Google Scholar 

  51. Klassen PS, Lowrie EG, Reddan DN, et al.: Association between pulse pressure and mortality in patients undergoing maintenance haemodialysis. JAMA 2002, 287:1548–1555.

    Article  PubMed  Google Scholar 

  52. De Nicola L, Minutolo R, Chiodini P et al.: Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006, 69:538–545.

    Article  PubMed  Google Scholar 

  53. Manjunath G, Tighiouart H, Ibrahim H et al.: Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community. J Am Coll Cardiol 2003, 41:47–55.

    Article  PubMed  Google Scholar 

  54. Chen J, Muntner P, Hamm LL et al.: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004 140:167–174.

    PubMed  Google Scholar 

  55. Segura J, Campo C, Ruilope LM: Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int 2004, 6(suppl 92):S1–S5.

    Google Scholar 

  56. Abbott KC, Bakris GL: What have we learned from the current trials? Med Clin North Am 2004, 88:189–207.

    Article  PubMed  Google Scholar 

  57. Gansevoort RT, de Jong PE: The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 2009, 20:465–468.

    Article  PubMed  Google Scholar 

  58. Feringa HH, Karagiannis SE, Chonchol M, et al.: Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors. J Am Soc Nephrol 2007, 18:1872–1879.

    Article  CAS  PubMed  Google Scholar 

  59. Jafar TH, Stark PC, Schmid CH, et al.: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003, 139:244–252.

    CAS  PubMed  Google Scholar 

  60. Kjeldsen S, Julius S: Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Am Heart J 2004, 148:747–754.

    Article  CAS  PubMed  Google Scholar 

  61. Casas JP, Chua W, Loukogeorgakis S et al.: Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005, 366:2026–2033.

    Article  CAS  PubMed  Google Scholar 

  62. Solomon SD, Rice MM, Jablonski K, et al.; Prevention of Events with ACE inhibition (PEACE) Investigators: Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 2006, 114:26–31.

    Article  CAS  PubMed  Google Scholar 

  63. Bakris GL, Sarafidis PA, Weir MR, et al.: Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010, 375:1173–1181.

    Article  CAS  PubMed  Google Scholar 

  64. Wanner C, Ritz E: Reducing lipids for CV protection in CKD patients—current evidence. Kidney Int Suppl 2008, 111:S24–S28.

    Article  CAS  PubMed  Google Scholar 

  65. Evans M, Fored CM, Bellocco R, et al.: Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 2009, 24:1908–1918.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Hypertension Unit, Hospital 12 de Octubre, Av. Cordoba, s/n., 28041, Madrid, Spain

    José A. García-Donaire & Luis M. Ruilope

Authors
  1. José A. García-Donaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José A. García-Donaire.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Donaire, J.A., Ruilope, L.M. Systolic Pressure, Diastolic Pressure, or Pulse Pressure as a Cardiovascular Risk Factor in Renal Disease. Curr Hypertens Rep 12, 307–312 (2010). https://doi.org/10.1007/s11906-010-0129-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0129-z

Keywords

Search

Navigation